Anti-STARD4 monoclonal antibody

Pre-made anti-STARD4 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to STARD4/STARD4 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2757-Ab-1/ GM-Tg-hg-IP2757-Ab-2Anti-Human STARD4 monoclonal antibodyHuman
GM-Tg-rg-IP2757-Ab-1/ GM-Tg-rg-IP2757-Ab-2Anti-Rat STARD4 monoclonal antibodyRat
GM-Tg-mg-IP2757-Ab-1/ GM-Tg-mg-IP2757-Ab-2Anti-Mouse STARD4 monoclonal antibodyMouse
GM-Tg-cynog-IP2757-Ab-1/ GM-Tg-cynog-IP2757-Ab-2Anti-Cynomolgus/ Rhesus macaque STARD4 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2757-Ab-1/ GM-Tg-felg-IP2757-Ab-2Anti-Feline STARD4 monoclonal antibodyFeline
GM-Tg-cang-IP2757-Ab-1/ GM-Tg-cang-IP2757-Ab-2Anti-Canine STARD4 monoclonal antibodyCanine
GM-Tg-bovg-IP2757-Ab-1/ GM-Tg-bovg-IP2757-Ab-2Anti-Bovine STARD4 monoclonal antibodyBovine
GM-Tg-equg-IP2757-Ab-1/ GM-Tg-equg-IP2757-Ab-2Anti-Equine STARD4 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2757-Ab-1/ GM-Tg-hg-IP2757-Ab-2; GM-Tg-rg-IP2757-Ab-1/ GM-Tg-rg-IP2757-Ab-2;
GM-Tg-mg-IP2757-Ab-1/ GM-Tg-mg-IP2757-Ab-2; GM-Tg-cynog-IP2757-Ab-1/ GM-Tg-cynog-IP2757-Ab-2;
GM-Tg-felg-IP2757-Ab-1/ GM-Tg-felg-IP2757-Ab-2; GM-Tg-cang-IP2757-Ab-1/ GM-Tg-cang-IP2757-Ab-2;
GM-Tg-bovg-IP2757-Ab-1/ GM-Tg-bovg-IP2757-Ab-2; GM-Tg-equg-IP2757-Ab-1/ GM-Tg-equg-IP2757-Ab-2
Products NameAnti-STARD4 monoclonal antibody
Formatmab
Target NameSTARD4
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-STARD4 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2757-Ag-1Recombinant multi-species STAR4/ STARD4 protein


    Target information

    Target IDGM-IP2757
    Target NameSTARD4
    Gene ID134429,170459,291699,706654,479141,101086371,100073191
    Gene Symbol and Synonyms4632419C16Rik,9030213J02Rik,STARD4
    Uniprot AccessionQ96DR4
    Uniprot Entry NameSTAR4_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000164211
    Target ClassificationN/A

    The target: STARD4, gene name: STARD4, also named as . Cholesterol homeostasis is regulated, at least in part, by sterol regulatory element (SRE)-binding proteins (e.g., SREBP1; MIM 184756) and by liver X receptors (e.g., LXRA; MIM 602423). Upon sterol depletion, LXRs are inactive and SREBPs are cleaved, after which they bind promoter SREs and activate genes involved in cholesterol biosynthesis and uptake. Sterol transport is mediated by vesicles or by soluble protein carriers, such as steroidogenic acute regulatory protein (STAR; MIM 600617). STAR is homologous to a family of proteins containing a 200- to 210-amino acid STAR-related lipid transfer (START) domain, including STARD4 (Soccio et al., 2002 [PubMed 12011452]).[supplied by OMIM, Mar 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.